Chimeric Therapeutics Statistics
Total Valuation
CHMMF has a market cap or net worth of 6.41 million. The enterprise value is 2.63 million.
| Market Cap | 6.41M |
| Enterprise Value | 2.63M |
Important Dates
The last earnings date was Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 893.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +94.34% |
| Shares Change (QoQ) | +69.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.90B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| PB Ratio | 4.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.38 |
| EV / Sales | 0.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72
| Current Ratio | 0.72 |
| Quick Ratio | 0.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -64.43 |
Financial Efficiency
Return on equity (ROE) is -469.35% and return on invested capital (ROIC) is -382.37%.
| Return on Equity (ROE) | -469.35% |
| Return on Assets (ROA) | -46.13% |
| Return on Invested Capital (ROIC) | -382.37% |
| Return on Capital Employed (ROCE) | -195.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CHMMF has paid 72,647 in taxes.
| Income Tax | 72,647 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.00% in the last 52 weeks. The beta is 1.54, so CHMMF's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | -92.00% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 20,438 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CHMMF had revenue of 8.32 million and -6.84 million in losses. Loss per share was -0.01.
| Revenue | 8.32M |
| Gross Profit | 7.76M |
| Operating Income | -8.91M |
| Pretax Income | -6.77M |
| Net Income | -6.84M |
| EBITDA | -8.24M |
| EBIT | -8.91M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3.77 million in cash and n/a in debt, giving a net cash position of 3.77 million.
| Cash & Cash Equivalents | 3.77M |
| Total Debt | n/a |
| Net Cash | 3.77M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.29M |
| Book Value Per Share | 0.00 |
| Working Capital | -2.68M |
Cash Flow
| Operating Cash Flow | -4.77M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 93.32%, with operating and profit margins of -107.18% and -82.23%.
| Gross Margin | 93.32% |
| Operating Margin | -107.18% |
| Pretax Margin | -81.36% |
| Profit Margin | -82.23% |
| EBITDA Margin | -99.05% |
| EBIT Margin | -107.18% |
| FCF Margin | n/a |
Dividends & Yields
CHMMF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -94.34% |
| Shareholder Yield | n/a |
| Earnings Yield | -106.73% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CHMMF has an Altman Z-Score of -6.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.34 |
| Piotroski F-Score | 3 |